# Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients

> **NCT01446185** · NA · COMPLETED · sponsor: **Genomic Health®, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Oncotype DX breast cancer test

## Key facts

- **NCT ID:** NCT01446185
- **Lead sponsor:** Genomic Health®, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446185, "Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01446185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*